Skip to main navigation Skip to search Skip to main content

New approach to screening drugs for activity against African trypanosomes

    Research output: Contribution to journal › Letter › peer-review

    Abstract

    THE African trypanosomes are unicellular eukaryotic parasites responsible for serious diseases in man (such as sleeping sickness) and domestic animals (such as nagana in cattle). The chemotherapy of these diseases is unsatisfactory1. Only a few drugs are available: these have serious side effects, drug resistance is a problem and “new drugs for clinical use are too expensive to develop and produce”2 using classical empirical screening methods. We report here how knowledge of trypanosome metabolism has led to a new method for screening drugs against trypanosomes. This could provide a short-cut to new drugs or drug combinations.
    Original languageEnglish
    Pages (from-to)270-271
    Number of pages2
    JournalNature
    Volume265
    Issue number5591
    DOIs
    Publication statusPublished - 1977

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    ASJC Scopus subject areas

    • General

    Fingerprint

    Dive into the research topics of 'New approach to screening drugs for activity against African trypanosomes'. Together they form a unique fingerprint.

    Cite this